
Overview
X-Tour focuses on machine learning models and molecular simulations for protein engineering and computational biology research. Its interests include predicting protein properties from sequence and structure, molecular dynamics, and validating predictions against laboratory data.
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk.
Filing timeliness
1 of 3 financial statements was filed late (for 2023, 570 days late).
- 202514/06/2026
- 202422/06/2025
- 202305/02/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Protein modeling
- Molecular simulations
- Biological sequence analysis
- Prediction validation
- Research API tools
Website technology
- Website
- Next.js
Authorized Representatives
Manner of representation
In the case of a management board consisting of two or more persons, joint action of two members of the management board, namely the President of the Management Board and a member of the management board, is required to make declarations on behalf of the company. In the case of the first management board, each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aleksandra Lewandowskaage 25 | 980 | $13,236.09 | 70% |
Hanna Małgorzata Syska Lewandowskaage 66 | 420 | $5,672.61 | 30% |
Aleksandra Lewandowska and Hanna Małgorzata Syska Lewandowska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-10-26.
93 1600 1055 1713 7438 5000 0001
04 1050 1298 1000 0090 8268 6537
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Actn3 Bioinformaticssp. z o.o. | $34,254.75 | actn3.pl | ||
| XTRNsp. z o.o. | $6,893.49 | xtrn.pl |
FAQ
Last updated: 2026-06-14